An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries

PURPOSE: Denosumab (administered via subcutaneous injection) demonstrated superior efficacy versus the intravenously administered zoledronic acid in the prevention of skeletal-related events in an integrated analysis of three head-to-head phase III trials in patients with bone metastases secondary t...

Descripción completa

Detalles Bibliográficos
Autores principales: Body, Jean-Jacques, Gatta, Francesca, De Cock, Erwin, Tao, Sunning, Kritikou, Persefoni, Wimberger, Pauline, Mebis, Jeroen, Peeters, Marc, Pedrazzoli, Paolo, Caraceni, Augusto, Adamo, Vincenzo, Hechmati, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527062/
https://www.ncbi.nlm.nih.gov/pubmed/28429148
http://dx.doi.org/10.1007/s00520-017-3697-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527062/
https://www.ncbi.nlm.nih.gov/pubmed/28429148
http://dx.doi.org/10.1007/s00520-017-3697-5

Ejemplares similares